3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Polycystic Ovary Syndrome
2
Insulin Resistance
1
Interventions
Metformin
18
Inositol
5
Exercise
4
Pioglitazone
3
Insulin
3
Ethinyl Estradiol
3
drospirenone and ethinyl estradiol combination
2
Surveys and Questionnaires
2
Cyproterone Acetate
2
Acupuncture Therapy
2
ziprasidone
1
salicylsalicylic acid
1
maltodextrin
1
licogliflozin
1
exendin (9-39)
1
drospirenone
1
cinnulin PF
1
Zoledronic Acid
1
Waist-Hip Ratio
1
Waist Circumference
1
Vitamin D
1
Time
1
Thioctic Acid
1
Tablets
1
Sulfasalazine
1
Sugars
1
Sodium-Glucose Transporter 2 Inhibitors
1
Sodium Salicylate
1
Saline Solution
1
Resistance Training
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Insulin Resistance
×
DLBS3233
×
Clear all
NCT01999686
2019-05-28
POSITIF
Dexa Medica Group
Phase 3
Completed
186 enrolled